首页> 外文期刊>Bone marrow transplantation >Risk factors for chronic kidney disease following acute kidney injury in pediatric allogeneic hematopoietic cell transplantation
【24h】

Risk factors for chronic kidney disease following acute kidney injury in pediatric allogeneic hematopoietic cell transplantation

机译:小儿同种异体造血细胞移植急性肾损伤后慢性肾病的危险因素

获取原文
获取原文并翻译 | 示例
       

摘要

Risk factors associated with the progression of acute kidney injury to chronic kidney disease in pediatric allogeneic hematopoietic cell transplantation (AlloHCT) recipients are not well described. We retrospectively investigated the risk factors for the progression to CKD in 275 AlloHCT recipients. AKI and CKD grading was defined according to the Kidney Disease Improving Global Outcomes classification. PRI90 was defined as persistent renal insufficiency (estimated GFR < 90 ml/min/1.73 m(2)) 90 days after the first episode of AKI. The median age was 9.1 years. Incidence of stages 1, 2, and 3 AKI were 43%, 41%, and 15%, respectively. 86.1% met our study criteria for PRI90. Of the 236 PRI90 patients, 213 and 152 patients were evaluable for CKD at 1 and 3 years, respectively. The incidence of CKD at 1 and 3 years was 63.1% and 62.9%, respectively. On multivariable analysis, estimated GFR at initial episode of AKI (<80 ml/min/1.73 m(2)) and estimated GFR (<70 ml/min/1.73 m(2)) at PRI90 was a risk factor associated with CKD development and both risk factors were associated with significantly lower overall survival. To conclude, eGFR at the time of AKI and PRI90 may be considered for screening pediatric AlloHCT recipients at risk for the progression to CKD.
机译:与小儿同种异体造血细胞移植(ALLOHCT)接受者进行急性肾脏损伤进展相关的危险因素并未详述。我们回顾了275个AlloHCT受体中进展的危险因素。根据肾病改善全球结果分类,均可定义AKI和CKD分级。 PRI90被定义为持续的肾功能不全(估计GFR <90 ml / min / 1.73米(2))在第一次发作后90天后的AKI。中位年龄为9.1岁。阶段1,2和3AKI的发病率分别为43%,41%和15%。 86.1%符合PRI90的研究标准。在236例PRI90患者中,213名和152名患者分别在1和3年内评估CKD。 1和3岁的CKD发病率分别为63.1%和62.9%。在多变量分析中,PRI90初始发作的初始发作(<80mL / min / 1.73m(2))和估计的GFR(<70ml / min / 1.73m(2))是与CKD发育相关的危险因素并且危险因素都与总生存率显着降低。为了得出结论,AKI和PRI90时的EGFR可以考虑筛查小儿allohct受体,以危险的进展对CKD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号